Men's Health
Conference Coverage
Anabolic-steroid withdrawal regimens show promise in men
“There is a vacuum of medical advice on what to do” when men stop taking steroids.
News from the FDA/CDC
Prostate cancer drug shortage leaves some with uncertainty
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
News
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Conference Coverage
Urine test predicts future bladder cancer 12 years before symptoms
The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
Commentary
Three surprising studies on exercise restriction and an exercise sweet spot
New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.
News
USPSTF recommends against routine herpes screening for asymptomatic teens and adults
The updated recommendation confirms that harms outweigh benefits for population-based genital HSV screening.
News
Can a hormone shot rescue low libido?
Two studies provide proof of concept for the development of kisspeptin-based therapeutics for men and women with distressing hypoactive sexual...
Commentary
Atrial fibrillation: Sex differences and modifiable risk factors
Experts examine to what extent greater height explains the differences in AF risk between men and women.
News
Nitroglycerin’s safety and value examined
Is it safe for a man with coronary artery disease who takes nitroglycerin to also take sildenafil?